96 related articles for article (PubMed ID: 22907147)
61. The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options.
Astrahan MA
J Contemp Brachytherapy; 2013 Mar; 5(1):23-32. PubMed ID: 23634152
[TBL] [Abstract][Full Text] [Related]
62. Smoking as a modifiable risk factor in eye diseases.
Gandhi JS
Eur J Ophthalmol; 2022 Oct; ():11206721221131613. PubMed ID: 36217762
[No Abstract] [Full Text] [Related]
63. Irreversible laser-induced maculopathy in a child.
Findlay Q; Balaratnasingam C; Mendis R
J Paediatr Child Health; 2016 Nov; 52(11):1044-1045. PubMed ID: 30240086
[No Abstract] [Full Text] [Related]
64. Laser-Induced Maculopathy.
Chen KJ
Ophthalmol Retina; 2017; 1(1):76. PubMed ID: 31047398
[No Abstract] [Full Text] [Related]
65. Laser Pointer Maculopathy.
Snyder L; Patel S
Ophthalmol Retina; 2018 Oct; 2(10):996. PubMed ID: 31047502
[No Abstract] [Full Text] [Related]
66. An immunotherapeutic artificial vitreous body hydrogel to control choroidal melanoma and preserve vision after vitrectomy.
Chen M; Hu J; Gao H; Shen J; Wei T; Yao J; Zhang Y; Gu P; Liu Z; Chen Q
Sci Adv; 2023 Nov; 9(44):eadh1582. PubMed ID: 37910617
[TBL] [Abstract][Full Text] [Related]
67. Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy.
Gulati SK; Pillai GS; Radhakrishnan N
Oman J Ophthalmol; 2019; 12(2):129-132. PubMed ID: 31198302
[TBL] [Abstract][Full Text] [Related]
68. Uveal Melanoma: Current Trends in Diagnosis and Management.
Tarlan B; Kıratlı H
Turk J Ophthalmol; 2016 Jun; 46(3):123-137. PubMed ID: 27800275
[TBL] [Abstract][Full Text] [Related]
69. Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma.
Wen JC; McCannel TA
Curr Opin Ophthalmol; 2009 May; 20(3):200-4. PubMed ID: 19349865
[TBL] [Abstract][Full Text] [Related]
70. Classification and treatment of radiation maculopathy.
Horgan N; Shields CL; Mashayekhi A; Shields JA
Curr Opin Ophthalmol; 2010 May; 21(3):233-8. PubMed ID: 20393294
[TBL] [Abstract][Full Text] [Related]
71. Management of radiation maculopathy.
Singh AD; Pabon S; Aronow ME
Ophthalmic Res; 2012; 48 Suppl 1():26-31. PubMed ID: 22907147
[TBL] [Abstract][Full Text] [Related]
72. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
73. Intravitreal pegaptanib sodium (Macugen) for radiation retinopathy following episcleral plaque radiotherapy.
Querques G; Prascina F; Iaculli C; Delle Noci N
Acta Ophthalmol; 2008 Sep; 86(6):700-1. PubMed ID: 18705681
[No Abstract] [Full Text] [Related]
74. Intravitreous ranibizumab (lucentis) for radiation maculopathy.
Finger PT; Chin KJ
Arch Ophthalmol; 2010 Feb; 128(2):249-52. PubMed ID: 20142553
[No Abstract] [Full Text] [Related]
75. INTRAVITREAL DEXAMETHASONE IMPLANT FOR RADIATION MACULOPATHY SECONDARY TO PLAQUE BRACHYTHERAPY IN CHOROIDAL MELANOMA.
Caminal JM; Flores-Moreno I; Arias L; Gutiérrez C; Piulats JM; Català J; Rubio MJ; Cobos E; García P; Pera J; Giralt J; Arruga J
Retina; 2015 Sep; 35(9):1890-7. PubMed ID: 26035401
[TBL] [Abstract][Full Text] [Related]
76. INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT AT 2-MONTH INTERVALS REDUCES FOVEAL AVASCULAR ZONE ENLARGEMENT AND VISION LOSS IN RADIATION MACULOPATHY: A Pilot Study.
Daruich A; Matet A; Schalenbourg A; Zografos L
Retina; 2019 Aug; 39(8):1519-1526. PubMed ID: 29746413
[TBL] [Abstract][Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
